The Platform
Technology & Manufacturing
BioXcellerator's manufacturing infrastructure and quality systems are not aspirational — they are operational, certified, and producing commercial-grade biologic products today.
Certifications
Regulatory & Quality Credentials
BioXcellerator holds a suite of certifications that are rare in the regenerative medicine category. Most operators in this space have none. The certifications below represent years of investment in quality systems, documentation, and regulatory compliance — and they are the foundation of the clinical credibility that drives patient outcomes and investor confidence.
International standard for quality management systems, covering all operational processes from donor sourcing through clinical delivery. One of multiple ISO certifications held across BioXcellerator's healthcare services and BioX Tech manufacturing division.
Current Good Manufacturing Practice alignment for biologic product manufacturing, ensuring consistency, safety, and quality at every production step.
Good Clinical Practice certification governing the ethical and scientific quality standards for clinical procedures and outcomes documentation.
Compliance with Colombia's national health regulatory authority, enabling legal operation of the Medellín flagship clinic and laboratory.
Positioned for U.S. operations under Utah's landmark regenerative medicine legislation, enabling licensed delivery of placental stem cell therapies domestically.
Manufacturing
In-House Manufacturing Infrastructure
Manufacturing in-house is the single most important structural decision BioXcellerator made. It means full control over quality, cost, supply, and the pace of innovation. No dependency on third-party CMOs. No margin leakage. No supply chain risk.
CDMO Revenue Opportunity
BioXcellerator's manufacturing infrastructure creates a CDMO (Contract Development and Manufacturing Organization) revenue stream — producing biologic products for third-party healthcare providers and operators. This is a capital-efficient revenue expansion that leverages existing infrastructure.